We are live on ! Find out more
OC

Oarsman Capital Portfolio holdings

AUM $806M
1-Year Est. Return 19.96%
This Fund
S&P 500
This Quarter Est. Return
+0.78%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$574M
AUM Growth
+$30.8M
Cap. Flow
+$31.5M
Cap. Flow %
5.49%
Top 10 Hldgs %
41.01%
Holding
959
New
52
Increased
253
Reduced
246
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 12.6%
2 Financials 5.07%
3 Communication Services 4.77%
4 Healthcare 4.3%
5 Industrials 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWJ icon
201
iShares MSCI Japan ETF
EWJ
$22B
$253K 0.04%
3,773
-861
-19% -$59.4K
TEQI icon
202
T. Rowe Price Equity Income ETF
TEQI
$466M
$252K 0.04%
6,212
+1
+0% +$42
EXPE icon
203
Expedia Group
EXPE
$35.8B
$252K 0.04%
1,351
-115
-8% -$19.8K
DE icon
204
Deere & Co
DE
$163B
$248K 0.04%
584
-24
-4% -$10.1K
CI icon
205
Cigna
CI
$74.5B
$247K 0.04%
895
AXP icon
206
American Express
AXP
$233B
$246K 0.04%
830
-26
-3% -$7.47K
WDAY icon
207
Workday
WDAY
$40.8B
$239K 0.04%
928
+51
+6% +$13K
TTE icon
208
TotalEnergies
TTE
$193B
$239K 0.04%
4,388
+525
+14% +$31.9K
UL icon
209
Unilever
UL
$137B
$236K 0.04%
3,700
+26
+0.7% +$1.76K
MRK icon
210
Merck
MRK
$316B
$235K 0.04%
2,365
-422
-15% -$43.5K
CTAS icon
211
Cintas
CTAS
$81.6B
$232K 0.04%
1,272
VLTO icon
212
Veralto
VLTO
$23.1B
$230K 0.04%
2,261
UAL icon
213
United Airlines
UAL
$41.7B
$224K 0.04%
2,304
-3,374
-59% -$285K
GSK icon
214
GSK
GSK
$103B
$221K 0.04%
6,528
+1,450
+29% +$52.2K
PLTR icon
215
Palantir
PLTR
$301B
$220K 0.04%
2,904
-446
-13% -$26K
ZBH icon
216
Zimmer Biomet
ZBH
$18.8B
$218K 0.04%
2,061
TXRH icon
217
Texas Roadhouse
TXRH
$13.8B
$218K 0.04%
1,206
-112
-8% -$21.1K
WSO icon
218
Watsco Inc
WSO
$13.1B
$215K 0.04%
453
SLV icon
219
iShares Silver Trust
SLV
$28B
$214K 0.04%
8,133
-927
-10% -$26.5K
STE icon
220
Steris
STE
$22.7B
$214K 0.04%
1,039
TRV icon
221
Travelers Companies
TRV
$78B
$211K 0.04%
877
TTD icon
222
Trade Desk
TTD
$8.6B
$208K 0.04%
1,766
+853
+93% +$106K
SNY icon
223
Sanofi
SNY
$103B
$207K 0.04%
4,292
-235
-5% -$11.9K
IWB icon
224
iShares Russell 1000 ETF
IWB
$49B
$207K 0.04%
642
-989
-61% -$320K
NXPI icon
225
NXP Semiconductors
NXPI
$56.5B
$205K 0.04%
988
+123
+14% +$28K

Similar funds

Oarsman Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Oarsman Capital held 959 positions worth $574M, up 5.7% from $543M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Oarsman Capital deployed $31.5M of net new capital in Q4 2024, opening 52 new positions and adding to 253 existing holdings. Its largest new stake was Leidos: 6,758 shares worth $974K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $1.4M trimmed.

  • Oarsman Capital's largest Q4 2024 buy was Leidos: 6,758 shares worth $974K.
  • Oarsman Capital added most to Vanguard Morningstar Value ETF in Q4 2024, an estimated $7.88M increase.
  • Oarsman Capital's biggest Q4 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.4M.
  • Oarsman Capital fully exited MGM Resorts International in Q4 2024, selling an estimated $227K.
  • Oarsman Capital's ten largest holdings make up 41% of its $574M portfolio in Q4 2024.
  • Oarsman Capital opened 52 new positions and closed 56 in Q4 2024.
  • Oarsman Capital's portfolio value rose 5.7% quarter-over-quarter to $574M.

Based on Oarsman Capital's 13F filing for Q4 2024, filed 13 Feb 2025.